Report pinpoints Midwest as bioscience powerhouse of the US
A new report from Ernst & Young has named the Midwest as Americas leading region for bioscience research.
The Midwest has grown to become the most vibrant bioscience research hub in the whole of the United States, a newly-published paper notes.
Despite the strength of universities and other research institutions on both the east and west coasts of the country, according to the latest industry report from Ernst & Young, it is the Midwest region which is currently leading the way when it comes to research and development.
Indeed, the nine state region, which include Illinois and Ohio, is now home to 16,800 biotechnology firms, employing more than 377,000 people.
In comparison, California boasts just 7,500 biotech companies, while the West Coast is also lagging behind in terms of university research, the paper also notes.
Welcoming the news, David Miller, president of Illinois-based iBIO, said: “The report shows not only that Illinois is a remarkably diversified biotech powerhouse but also that our state is at the heart of a Midwest region that easily holds its own with either coast.”
This comes just days after the Industrial Technology and Enterprise Advisory Council approved several million dollars worth of new funding for the Ohio Clinical Trials Collaborative initiative.
Related News
-
News CPHI Milan 2024 - From the Floor
Milan and CPHI welcome you to 2024 CPHI Milan! As we celebrate the 35th edition of our flagship CPHI show, editors Vivian Xie and Lucy Chard bring you the latest from the show floor, conference sessions, and innovative solutions from all exhibitors, at... -
News The BIOSECURE Act: implications for the pharma supply chain
On September 9, 2024, the US House of Representatives voted to pass the bill titled the BIOSECURE Act (the Act), which lists several Chinese companies in the pharmaceutical supply chain. The Act will prohibit American companies from contracting or doin... -
News A Day in the Life of a Global CDMO Chapter Lead – Manufacturing
The 'Day in the Life of' series has covered many aspects of the pharmaceutical pipeline, including R&D and procurement, now we're taking a look at manufacturing from a global CDMO perspective. -
News CPHI Milan Speaker Spotlight: CDMO relations with Pharma and Start-Ups
In the run-up to CPHI Milan, we sit down with some of the experts and thought-leaders speaking at this year’s conferences. -
News Women in Pharma: Advocating for trans healthcare in pharma
In our monthly series on women in the pharmaceutical industry, we interview leading experts in the pharmaceutical supply and value chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News Updated – Changing abortion pill access according to the US FDA and Supreme Court
After the approval of the medical abortion pill, mifepristone, by the US FDA, states across the USA approach the distribution of the pill differently, some ruling against allowing access to the drug. -
News CPHI North America 2024 – From the Floor
Welcome to Philly! CPHI North America once again graces the Philadelphia Convention Center, 7–9 May 2024. -
News Drug Patent Expiries: a steep cliff or opportunity for innovation?
The pharmaceutical industry faces a patent cliff together in the years leading up to 2030. Learn what this means for drug pricing, their outsourcing partners, and drug innovation of the future.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance